Genetics: Clonal and subclonal events in cancer evolution-optimizing cancer therapy

Nature Reviews Clinical Oncology

Volumn 12, Issue 7, 2015, Pages 372-

  Errico, Alessia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AKT GENE; APOBEC GENE; BRAF GENE; CANCER CELL; CANCER THERAPY; COPY NUMBER VARIATION; GENE MUTATION; GENE TARGETING; IDH1 GENE; LUNG CANCER; MTOR GENE; NOTE; ONCOGENE; PI3K GENE; PIK3CA GENE; PRIORITY JOURNAL; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NEOPLASM; NUCLEOTIDE SEQUENCE;

DNA MUTATIONAL ANALYSIS; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASMS;

EID: 84933277383     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2015.87     Document Type: Note

References (1)

1. McGranahan N., et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 283, 283ra54 (2015